ARTIA GLOBAL PARTNERS LP
Q1 2026 Form 13-F
MIAMI, FLORIDA
CIK 0001937964
· CRD 322091
· SEC-registered investment adviser
$499.4M Reported Value Total
ARTIA GLOBAL PARTNERS LP reports 3 total accounts under management (AUM). There are 3 discretionary accounts valued at $778,890,878, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
1 fund
· $778.9M gross asset value
Hedge Fund: $778.9M
Source: Form ADV filed 2026-03-31
Reported value
$499.4M
Quarter over quarter
-8.3%
Holdings
48
Top-10 concentration
71.5%
Key People
Form ADV owners & control persons
Onusa Nmn Chantanapongwanij
MANAGING PARTNER
William Christopher Verdi
CHIEF COMPLIANCE OFFICER AND CHIEF FINANCIAL OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2026 13F record
Q1 2026 13F filing summary
| Period of report | March 31, 2026 |
|---|---|
| Filed | May 15, 2026 |
| Form | 13F-HR |
| Reported value | $499.4M |
| Positions | 48 |
| Change in reported value | -29.2% |
| New positions | 10 |
| Exited positions | 12 |
| Position turnover | 36.7% |
| Top-10 concentration | 71.5% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
47 | $541.9M |
|
Q1 2026 13F
Filed May 15, 2026
|
48 | $499.4M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
50 | $705.8M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
48 | $630.9M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
33 | $415.6M |
|
Q1 2025 13F
Filed May 15, 2025
|
32 | $395.1M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
33 | $279.8M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
44 | $366.9M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
42 | $517.3M |
|
Q1 2024 13F
Filed May 15, 2024
|
47 | $497.5M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
27 | $343.7M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
27 | $240.6M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
34 | $290.1M |
|
Q1 2023 13F
Filed May 15, 2023
|
32 | $270.6M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
24 | $262.4M |
Top 20 holdings · Q1 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | INSM INSMED INC | $102.8M | 20.59% |
| 2 | ABVX ABIVAX SA | $66.9M | 13.39% |
| 3 | INSM P INSMED INC | $45.7M | 9.16% |
| 4 | LLY ELI LILLY & CO | $35.2M | 7.04% |
| 5 | TRVI TREVI THERAPEUTICS INC | $24.0M | 4.81% |
| 6 | ARGX ARGENX SE | $21.7M | 4.35% |
| 7 | AZN ASTRAZENECA PLC | $18.8M | 3.77% |
| 8 | NAMS NEWAMSTERDAM PHARMA COMPANY | $16.1M | 3.23% |
| 9 | DNTH DIANTHUS THERAPEUTICS INC | $13.7M | 2.74% |
| 10 | RVMD REVOLUTION MEDICINES INC | $12.2M | 2.43% |
| 11 | IONS IONIS PHARMACEUTICALS INC | $10.8M | 2.17% |
| 12 | MRNA C MODERNA INC | $10.2M | 2.03% |
| 13 | EYPT EYEPOINT INC | $9.9M | 1.98% |
| 14 | DGX QUEST DIAGNOSTICS INC | $8.0M | 1.6% |
| 15 | ALMS ALUMIS INC | $7.2M | 1.43% |
| 16 | VKTX VIKING THERAPEUTICS INC | $5.9M | 1.18% |
| 17 | MRK MERCK & CO INC | $5.6M | 1.12% |
| 18 | TERN TERNS PHARMACEUTICALS INC | $5.5M | 1.11% |
| 19 | JNJ JOHNSON & JOHNSON | $5.5M | 1.11% |
| 20 | SION SIONNA THERAPEUTICS INC | $4.8M | 0.96% |
Values as reported on the Q1 2026 Form 13F. Every position is in the holdings table below.